Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: BIOLOGICAL: tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell vaccine|DRUG: gemcitabine hydrochloride
Sponsor: Joseph Baar, MD, PhD